Cathelicidin antimicrobial peptide: A novel regulator of islet function, islet regeneration, and selected gut bacteria

Diabetes

Volumn 64, Issue 12, 2015, Pages 4135-4147

  Pound, Lynley D ^a   Patrick, Christopher ^a   Eberhard, Chandra E ^a   Mottawea, Walid ^b,c   Wang, Gen Sheng ^a   Abujamel, Turki ^a,b   Vandenbeek, Roxanne ^a   Stintzi, Alain ^b   Scott, Fraser W ^a,d  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c MANSOURA UNIVERSITY   (Egypt)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; GLUCAGON; INSULIN; ANTIDIABETIC AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; CATHELICIDIN LL-37 (18-29), HUMAN; GASTROINTESTINAL AGENT; PEPTIDE FRAGMENT;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR CALCIUM; GENE EXPRESSION; GLUCAGON RELEASE; HORMONE RELEASE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INSULIN RELEASE; INTESTINE FLORA; MALE; NONHUMAN; PANCREAS ISLET CELL FUNCTION; PANCREAS REGENERATION; PARACRINE SIGNALING; PRIORITY JOURNAL; RAT; TISSUE REGENERATION; UPREGULATION; AGONISTS; ANIMAL; CALCIUM SIGNALING; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; DYSBIOSIS; GENE EXPRESSION PROFILING; GENETICS; GERMFREE ANIMAL; INBRED RAT STRAIN; INTESTINE MUCOSA; JEJUNUM; METABOLISM; MICROBIOLOGY; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PATHOLOGY; PHYSIOLOGY; REGENERATION; SECRETION (PROCESS); TISSUE CULTURE TECHNIQUE;

AGED; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL PROTEINS; CALCIUM SIGNALING; CATHELICIDINS; DIABETES MELLITUS, TYPE 1; DYSBIOSIS; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION PROFILING; GERM-FREE LIFE; GLUCAGON; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTESTINAL MUCOSA; ISLETS OF LANGERHANS; JEJUNUM; MALE; MICE, INBRED NOD; PEPTIDE FRAGMENTS; RATS, INBRED STRAINS; REGENERATION; TISSUE CULTURE TECHNIQUES;

EID: 84962190977     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-0788     Document Type: Article

References (48)

1. Lefebvre DE, Powell KL, Strom A, Scott FW. Dietary proteins as environmental modifiers of type 1 diabetes mellitus. Annu Rev Nutr 2006;26:175-202
2. Snell-Bergeon JK, Smith J, Dong F, et al. Early childhood infections and the risk of islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetes Care 2012;35:2553-2558
3. Patrick C, Wang GS, Lefebvre DE, et al. Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial peptide. Diabetes 2013;62:2036-2047
4. Gulden E, Wong FS, Wen L. The gut microbiota and type 1 diabetes. Clin Immunol. 4 June 2015 [Epub ahead of print]. DOI: 10.1016/j.clim.2015. 05.01310.1016/j.clim.2015.05.013
5. Mojibian M, Chakir H, Lefebvre DE, et al. Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes 2009;58:1789-1796
6. Hilchie AL, Wuerth K, Hancock RE. Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. Nat Chem Biol 2013;9:761-768
7. Vandamme D, Landuyt B, Luyten W, Schoofs L. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol 2012;280:22-35
8. Wang GS, Kauri LM, Patrick C, Bareggi M, Rosenberg L, Scott FW. Enhanced islet expansion by beta-cell proliferation in young diabetes-prone rats fed a protective diet. J Cell Physiol 2010;224:501-508
9. Wang Y, Jacovetti C, Li B, et al. Coordinated age-dependent and pancreatic-specific expression of mouse Reg2Reg3a, and Reg3b genes. Growth Factors 2011;29:72-81
10. Zhang Z, Cherryholmes G, Chang F, Rose DM, Schraufstatter I, Shively JE. Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils. Eur J Immunol 2009;39:3181-3194
11. Pound LD, Sarkar SA, Benninger RK, et al. Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion. Biochem J 2009;421:371-376
12. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45
13. Srakaew N, Young CD, Sae-wu A, et al. Antimicrobial host defence peptide, LL-37, as a potential vaginal contraceptive. Hum Reprod 2014;29:683-696
14. Pound LD, Oeser JK, O'Brien TP, et al. G6PC2: a negative regulator of basal glucose-stimulated insulin secretion. Diabetes 2013;62:1547-1556
15. Abujamel T, Cadnum JL, Jury LA, et al. Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole. PLoS One 2013;8:e76269
16. Arthur JC, Perez-Chanona E, Mühlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012;338:120-123
17. Caron AZ, He X, Mottawea W, et al. The SIRT1 deacetylase protects mice against the symptoms of metabolic syndrome. FASEB J 2014;28:1306-1316
18. Sundquist A, Bigdeli S, Jalili R, et al. Bacterial flora-typing with targeted, chip-based Pyrosequencing. BMC Microbiol 2007;7:108
19. Magoc T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 2011;27:2957-2963
20. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335-336
21. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60
22. Yang SN, Shi Y, Yang G, Li Y, Yu J, Berggren PO. Ionic mechanisms in pancreatic b cell signaling. Cell Mol Life Sci 2014;71:4149-4177
23. Bode HP, Weber S, Fehmann HC, Göke B. A nutrient-regulated cytosolic calcium oscillator in endocrine pancreatic glucagon-secreting cells. Pflugers Arch 1999;437:324-334
24. de Goffau MC, Fuentes S, van den Bogert B, et al. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia 2014; 57:1569-1577
25. Vaarala O. The gut as a regulator of early inflammation in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2011;18:241-247
26. Davis-Richardson AG, Triplett EW. A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes. Diabetologia 2015;58:1386-1393
27. Kauri LM, Wang GS, Patrick C, Bareggi M, Hill DJ, Scott FW. Increased islet neogenesis without increased islet mass precedes autoimmune attack in diabetes-prone rats. Lab Invest 2007;87:1240-1251
28. Cryer PE, Gerich JE. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. N Engl J Med 1985;313:232-241
29. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 1973;182:171-173
30. Siafarikas A, Johnston RJ, Bulsara MK, O'Leary P, Jones TW, Davis EA. Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes. Diabetes Care 2012;35:1757-1762
31. Brugman S, Klatter FA, Visser JT, et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 2006;49:2105-2108
32. Giongo A, Gano KA, Crabb DB, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 2011;5:82-91
33. Kostic AD, Gevers D, Siljander H, et al.; DIABIMMUNE Study Group. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 2015;17:260-273
34. Tai EK, Wu WK, Wong HP, Lam EK, Yu L, Cho CH. A new role for cathelicidin in ulcerative colitis in mice. Exp Biol Med (Maywood) 2007;232:799-808
35. Sakane N, Kotani K, Tsuzaki K, et al. Equol producers can have low leptin levels among prediabetic and diabetic females. Ann Endocrinol (Paris) 2014;75: 25-28
36. Tikkanen MJ, Wähälä K, Ojala S, Vihma V, Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA 1998;95:3106-3110
37. Horiuchi H, Harada N, Adachi T, Nakano Y, Inui H, Yamaji R. S-equol enantioselectively activates cAMP-protein kinase A signaling and reduces alloxan-induced cell death in INS-1 pancreatic β-cells. J Nutr Sci Vitaminol (Tokyo) 2014;60:291-296
38. Frohm M, Agerberth B, Ahangari G, et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997;272:15258-15263
39. Gambichler T, Bechara FG, Scola N, Rotterdam S, Altmeyer P, Skrygan M. Serum levels of antimicrobial peptides and proteins do not correlate with psoriasis severity and are increased after treatment with fumaric acid esters. Arch Dermatol Res 2012;304:471-474
40. Kreuter A, Jaouhar M, Skrygan M, et al. Expression of antimicrobial peptides in different subtypes of cutaneous lupus erythematosus. J Am Acad Dermatol 2011;65:125-133
41. Sato-Deguchi E, Imafuku S, Chou B, Ishii K, Hiromatsu K, Nakayama J. Topical vitamin D? analogues induce thymic stromal lymphopoietin and cath-elicidin in psoriatic skin lesions. Br J Dermatol 2012;167:77-84
42. Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007;13: 975-980
43. Coffelt SB, Marini FC, Watson K, et al. The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mes-enchymal stromal cells. Proc Natl Acad Sci USA 2009;106:3806-3811
44. Li D, Beisswenger C, Herr C, et al. Expression of the antimicrobial peptide cathelicidin in myeloid cells is required for lung tumor growth. Oncogene 2014; 33:2709-2716
45. Ren SX, Shen J, Cheng AS, et al. FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells. PLoS One 2013;8:e63641
46. To KK, Ren SX, Wong CC, Cho CH. Reversal of ABCG2-mediated multidrug resistance by human cathelicidin and its analogs in cancer cells. Peptides 2013; 40:13-21
47. Chereddy KK, Her CH, Comune M, et al. PLGA nanoparticles loaded with host defense peptide LL37 promote wound healing. J Control Release 2014;194: 138-147
48. Yang YH, Wu WK, Tai EK, et al. The cationic host defense peptide rCRAMP promotes gastric ulcer healing in rats. J Pharmacol Exp Ther 2006;318:547-554